权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

USING CONTINGENCY MANAGEMENT TO PROMOTE ADHERENCE TO SMOKING CESSATION TREATMENT AMONG HOSPITALIZED SMOKERS

利用应急管理促进住院吸烟者坚持戒烟治疗

基本信息

批准号：
10672234
负责人：
Erica Nichols Cruvinel
金额：
$ 17.19万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-01 至 2027-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10672234
关键词：
Abstinence Address Adherence Area Behavior Behavioral Biochemical Caring Clinical Clinical Trials Combined Modality Therapy Counseling Data Development Future Goals Health Hospitalization Hospitals Incentives Inpatients Intervention Interview Kansas Knowledge Length of Stay Link Medicaid Medical center Mentors Methods Morbidity - disease rate Outcome Participant Patients Pharmaceutical Preparations Pharmacotherapy Postdoctoral Fellow Procedures Randomized Randomized, Controlled Trials Reporting Research Research Personnel Smoker Smoking Smoking Cessation Intervention Structure Surveys System Telefacsimile Telephone Testing Tobacco Tobacco Dependence Training Underserved Population Universities acceptability and feasibility alcohol tobacco and other drug use arm behavior change behavioral clinical trial care delivery career clinical practice contingency management design effective therapy efficacy study efficacy trial evidence base experience feasibility testing financial incentive follow-up improved innovation intervention refinement mHealth medication compliance mortality nicotine gum novel novel strategies patient engagement payment pill quitline randomized trial recruit remote delivery research study skills success text messaging intervention therapy development tobacco cessation intervention tobacco user varenicline wasting

项目摘要

PROJECT SUMMARY/ABSTRACT Each year, nearly 4 million smokers are hospitalized in the US, creating an important opportunity to initiate to- bacco cessation treatment. However, smoking cessation treatment started in the hospital must continue at least 1 month post-discharge to be effective. Many hospitals refer smokers to state-sponsored tobacco quitlines to provide counseling follow up. A recent clinical trial found that varenicline use initiated during the hospital stay in combination with post-discharge quitline support increased smokers’ likelihood of quitting by 78%. Nevertheless, most inpatient smokers rarely actually register with the quitline, and those who do register participate in very few sessions. Furthermore, most smokers never fill their prescriptions for post-discharge cessation medications. Novel approaches are needed to engage hospitalized smokers in medication and counseling to increase their odds of quitting. Contingency management (CM) intervention provides financial incentives contingent upon ob- jective evidence of behavior change and is an effective approach to increase engagement in quitline calls and to increase rates of compliance with nicotine gum. Critical gaps remain in our knowledge about how best to deploy CM. CM has not been tested for increasing treatment engagement post-hospitalization. Remote delivery of CM via mobile health (mHealth) has not been tested for smoking cessation treatment. More broadly, CM approaches for concurrently incentivizing combined interventions (such as pharmacotherapy + behavioral sup- port) are lacking. The purpose of the proposed research is to develop and test the feasibility and preliminary efficacy of an mHealth-delivered CM intervention to increase hospitalized smokers’ post-discharge engagement in counseling and pharmacotherapy. The proposed research study has the following specific aims: 1) develop a text-based intervention (CounsCM+MedCM) to remotely incentivize engagement in quitline calls and varenicline utilization among post-discharged smokers; 2) to use mixed methods to understand strengths, weaknesses, and areas for improvement of CounsCM+MedCM; 3) to evaluate the feasibility, acceptability, and preliminary efficacy of CounsCM+MedCM compared to noncontingent “yoked” control (NCYC), in a pilot randomized controlled trial. Dr. Cruvinel is a postdoctoral associate at the University of Kansas Medical Center with experience and training in interventions to address tobacco, alcohol and other drug use. Dr. Cruvinel’s career goal is to reduce tobacco- related morbidity and mortality of hospitalized smokers through novel systems of evidence-based care delivery, with an emphasis on mHealth interventions for underserved populations. The primary training goals of this pro- posal are to gain skills in pharmaco-and behavioral clinical trials, mHealth intervention development, and to develop expertise in CM interventions. The results of the proposed research and training plans will facilitate Dr. Cruvinel's development as an independent investigator and provide preliminary data for a future large-scale efficacy study.

项目总结/文摘